אינג'י 10 מג20 מג טבליות

Country: Ísrael

Tungumál: hebreska

Heimild: Ministry of Health

Virkt innihaldsefni:

EZETIMIBE; SIMVASTATIN

Fáanlegur frá:

MERCK SHARP & DOHME ISRAEL LTD

ATC númer:

C10AA01

Lyfjaform:

טבליה

Samsetning:

EZETIMIBE 10 MG; SIMVASTATIN 20 MG

Stjórnsýsluleið:

פומי

Gerð lyfseðils:

מרשם נדרש

Framleitt af:

MERCK SHARP & DOHME (ITALIA) S.P.A.

Meðferðarhópur:

SIMVASTATIN

Lækningarsvæði:

SIMVASTATIN

Ábendingar:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH. Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

Leyfisdagur:

2012-04-30